EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

ORL@Cu‐MOF Boost Cuproptosis and Suppress Fatty Acid Metabolism for Cancer Lymph Node Metastasis Synergistic Therapy

Zi-Zhan Li iD, Yi Liu, Kan Zhou, Lei-Ming Cao, Guang-Rui Wang, Jinmei Wu, Yi-Fu Yu, Yao Xiao, Bing Liu, Qiuji Wu, Zhiyong Song, Lin-Lin Bu iD

Advanced Science · 2025

DOI: 10.1002/advs.202502154 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2025. Verfasst von Zi-Zhan Li und 11 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Lab…. Hauptthemen laut MEDLINE: Metal-Organic Frameworks, Fatty Acids, Lymphatic Metastasis, Orlistat. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hubei Province Chinese Medicine Research Project, Natural Science Foundation of Hubei Province, Medical Young Talents Program of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymph node metastasis (LNM) is one of the significant characteristics of poor prognosis in oral squamous cell carcinoma (OSCC), strongly associated with high mortality rates. Immunotherapy has emerged as a crucial treatment modality for OSCC LNM, yet its limited response rate severely restricts its clinical application. Cuproptosis, a newly discovered immunogenic cell death (ICD), is often hindered by lipid metabolic reprogramming in tumor cells, which also contributes significantly to the lack of response to immunotherapy. Herein, a metal‐organic framework (MOF) nanodrug loaded with orlistat (ORL) is developed, designated as ORL@Cu‐MOF. This nanodrug is designed to respond and release under the high glutathione (GSH) stimulus of the tumor microenvironment (TME), thereby inducing cuproptosis and suppressing fatty acid metabolism in OSCC cells. In vivo, ORL@Cu‐MOF effectively triggers cuproptosis and inhibits fatty acid metabolism, exerting antitumor effects in mouse models and remodeling the TME. Furthermore, the combination of ORL@Cu‐MOF with programmed death receptor‐1 (αPD‐1) significantly enhances immunotherapy outcomes, transforming “cold tumors” into “hot tumors”. This study is the first to report the synergistic use of cuproptosis induction and fatty acid metabolism suppression in the treatment of metastatic cancer, offering novel insights for the care and management of LNM of OSCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Metal-Organic FrameworksFatty AcidsLymphatic MetastasisOrlistatMouth NeoplasmsAnimalsMiceHumansCell Line, TumorCopperTumor MicroenvironmentImmunotherapyImmunogenic Cell Death

Stichwörter der Autor:innen

cuproptosisimmunotherapylipid metabolic reprogramminglymph node metastasisnanomedicine

Substanzen

Metal-Organic FrameworksFatty AcidsCopperOrlistat

Autor:innen und Institutionen

  • State Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, Key Laboratory of Oral Biomedicine Ministry of Education, Hubei Key Laboratory of Stomatology, School & Hospital of Stomatology, Wuhan Univer…
  • Department of Oral & Maxillofacial - Head Neck Oncology, School & Hospital of Stomatology, Wuhan University, Wuhan, 430079, China.
  • National Key Laboratory of Agricultural Microbiology, College of Chemistry, Huazhong Agricultural University, Wuhan, 430070, China.
  • Key Laboratory of Combinatorial Biosynthesis and Drug Discovery, School of Pharmaceutical Sciences, Wuhan University, Wuhan, 430071, China.
  • Department of Radiation and Medical Oncology, Hubei Key Laboratory of Tumor Biological Behaviors, Hubei Cancer Clinical Study Center, Zhongnan Hospital of Wuhan University, Wuhan, 430071, China.

ORCID-Profile: Zi-Zhan Li, Lin-Lin Bu

Förderung

  • Hubei Province Chinese Medicine Research Project
  • Natural Science Foundation of Hubei Province
  • Medical Young Talents Program of Hubei Province
  • Wuhan Young Medical Talents Training Project
  • Youth Interdisciplinary Special Fund of Zhongnan Hospital of Wuhan University
  • Translational Medicine and Interdisciplinary Research Joint Fund of Zhongnan Hospital of Wuhan University
  • State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Li, Z. Z., Liu, Y., Zhou, K., Cao, L. M., Wang, G. R., Wu, J., Yu, Y. F., Xiao, Y., Liu, B., Wu, Q., Song, Z., & Bu, L. L. (2025). ORL@Cu‐MOF Boost Cuproptosis and Suppress Fatty Acid Metabolism for Cancer Lymph Node Metastasis Synergistic Therapy. Advanced Science. https://doi.org/10.1002/advs.202502154

Vancouver

Li ZZ, Liu Y, Zhou K, Cao LM, Wang GR, Wu J, et al. ORL@Cu‐MOF Boost Cuproptosis and Suppress Fatty Acid Metabolism for Cancer Lymph Node Metastasis Synergistic Therapy. Advanced Science. 2025. doi:10.1002/advs.202502154

BibTeX
@article{Li2025,
  author = {Li, Zi-Zhan and Liu, Yi and Zhou, Kan and Cao, Lei-Ming and Wang, Guang-Rui and Wu, Jinmei and Yu, Yi-Fu and Xiao, Yao and Liu, Bing and Wu, Qiuji and Song, Zhiyong and Bu, Lin-Lin},
  title = {ORL@Cu‐MOF Boost Cuproptosis and Suppress Fatty Acid Metabolism for Cancer Lymph Node Metastasis Synergistic Therapy},
  journal = {Advanced Science},
  year = {2025},
  doi = {10.1002/advs.202502154}
}
Kostenlos starten →